Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.

Michelle L Tas Michelle Nagtegaal Kathelijne C J M Kraal Godelieve A M TytgatNico G G M AbelingJan Koster Saskia M F Pluijm Christian Michel Zwaan Bart de Keizer Jan J Molenaar Max M Van Noesel

Published in: Pediatric blood & cancer (2019)

Patients < 4 weeks old with neuroblastoma stage 4S are at risk of fatal outcome caused by progression of liver metastases. In other patients, tumor regression is characterized by a rapid biochemical normalization that precedes radiological regression.

Keyphrases

end stage renal disease
risk factors
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
liver metastases
peritoneal dialysis
multiple sclerosis
patient reported outcomes
patient reported
gestational age